ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,544.59
      -0.78%
      US Tech 100
      19,100.40
      -0.41%
      Dow Jones
      40,665.02
      -1.29%
      Brent Oil
      84.105
      0.03%
      Bitcoin
      63,423.12
      -0.85%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. MoonLake Immunotherapeutics (MLTX)

      7. MoonLake Immunotherapeutics (MLTX) Financials

      MoonLake Immunotherapeutics

      MoonLake Immunotherapeutics (MLTX)

      NASDAQ
      45.02
      -1.46
      (-3.14%)
      Closed July 18 4:00PM
      Delayed by 15 minutes
      45.02
      0.00
      ( 0.00% )
      Pre Market: 4:00AM
      Delayed by 15 minutes

      MoonLake Immunotherapeutics Financial Summary

      The current MLTX market cap is 2.88B. The company's latest EPS is USD -0.6901 and P/E is -65.24.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -12.93M-13.19M-12.98M-15.03M-19.82M
      Net Income -12.22M-12.35M-11.62M-7.89M-13.98M
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Total Revenue 0000
      Operating Income -106k-4.57M-65.06M-54.12M
      Net Income -91k-4.54M-64.51M-44.08M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)
      Total Assets 66.8M506.62M500.22M526.54M564.12M
      Total Liabilities 7.69M7.51M10.58M13.05M11.73M
      Total Equity 59.11M499.11M489.64M513.49M552.39M
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Total Assets 116.63M115.84M76.84M526.54M
      Total Liabilities 4.15M7.9M8.08M13.05M
      Total Equity 5M-7.06M68.77M513.49M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)
      Operating -9.02M-21.18M-30.43M-42.78M-14.95M
      Investing 19.65M32.33M-142.05M-25.19M-28.8M
      Financing N/A 451.29M451.29M479.7M50.98M
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Operating -317k-611k-55.89M-42.78M
      Investing -115M N/A -32.34M-25.19M
      Financing 116.65M-58k119.69M479.7M

      Stats and Ratios

      Market Cap 2.88B
      Price to Earnings Ratio -65.24
      Price to Sales Ratio 0
      Price to Cash Ratio 6.37
      Price to Book Ratio 5.6
      Dividend Yield -

      Share Statistics

      Shares Outstanding 63.87M
      Average Volume (1 week) 526.48k
      Average Volume (1 Month) 441.23k
      52 Week Change -23.73%
      52 Week High 64.98
      52 Week Low 35.11
      Spread (Intraday) 30.47 (62.82%)

      Company Info

      Company Name MoonLake Immunotherapeutics
      Address p.o. box 309
      grand cayman 1104
      Website https://moonlaketx.com
      Industry pharmaceutical preparations (2834)